Sandrine BASAGLIA-PAPPAS

Dr. Sandrine BASAGLIA-PAPPAS

Cognitive Psychology and Neuropsychology, University of Mons, Mons, Wallonia, Belgium
+1
orcid
Cognitive Psychology and Neuropsychology departement, Mons, ...

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Sandrine BASAGLIA-PAPPASSandrine BASAGLIA-PAPPAS
Sandrine BASAGLIA-PAPPAS
BLBernard Laurent
Bernard Laurent
JGJean-Claude Getenet
Jean-Claude Getenet
ABAnne Boulangé
Anne Boulangé
ALAurelia Rendón de Lacruz
Aurelia Rendón de Lacruz
LLLaurent Lefebvre
Laurent Lefebvre
The logopenic variant of primary progressive aphasia (lvPPA) shows different features from the non-fluent (nfvPPA) and semantic (svPPA) variants of PPA. Although language impairments remain the core symptoms, studies have highlighted the presence of executive disorders at the onset of the disease. Nevertheless, the results are contradictory, particularly in lvPPA. The aim of this study was to explore the executive profile of lvPPA. We compared executive functioning in lvPPA with the other two variants of PPA, Alzheimer’s disease (AD) and a cognitively healthy group. In total, 70 patients with PPA, 32 patients with AD, and 41 healthy controls were included. They underwent a comprehensive executive battery assessing short-term and working memory, inhibition, flexibility, planning, and initiation. The analyses showed significant differences between the lvPPA group and the control group, except on visuospatial spans and the Stroop test, and between the lvPPA group and the other PPA groups and the AD group for several tasks. Thus, this research highlighted the existence of an executive dysfunction from the onset of the disease in lvPPA but also in the other two variants of PPA.

27 September 2023 in L’Année psychologique
Verified
Journal Article
Closed access
Sandrine BASAGLIA-PAPPASSandrine BASAGLIA-PAPPAS
Sandrine BASAGLIA-PAPPAS
RBRomane Bourgey
Romane Bourgey
ABAnne Boulangé
Anne Boulangé
PAPauline Amiot
Pauline Amiot
ÉCÉlise Champeaux
Élise Champeaux
ILIsabelle Simoes Loureiro
Isabelle Simoes Loureiro
Les troubles lexico-sémantiques sont connus pour être l’une des manifestations majeures de l’aphasie, qu’elle soit d’origine vasculaire (comme l’aphasie sémantique -AS-) ou dégénérative (comme l’aphasie sémantique progressive primaire -APPvs- et la maladie d’Alzheimer -MA-). En pratique clinique, ces troubles sont principalement évalués par des tests verbaux, alors que, selon la littérature, le déficit doit être observé dans plusieurs modalités. Le but de cette étude était de créer une batterie française d’évaluation sémantique multimodale appelée EMCS (Évaluation Multimodale des Connaissances Sémantiques), qui étudie, en un temps plus court que les outils existants, l’efficacité de la mémoire sémantique à travers plusieurs tâches multimodales. Quatre-vingt-sept participants témoins français ont été recrutés. Ils ont subi les 10 tâches de la batterie EMCS, à savoir les modalités verbales et non verbales. Pour explorer la sensibilité de la batterie, trois patients AS, deux APPvs et deux MA au stade débutant de la maladie ont réalisé l’EMCS. Analyses et résultats : Les analyses statistiques ont permis d’établir des données normatives, avec des scores en percentiles, et ont mis en évidence, pour les témoins, un effet du niveau d’éducation pour la majorité des tests, un effet d’âge pour plusieurs tâches, mais pas d’effet de sexe. Pour chaque patient, les résultats se sont montrés discriminants par rapport au groupe témoin de référence pour plusieurs tâches, à savoir la dénomination d’images, les connaissances sémantiques sur les célébrités et l’épreuve gustative (p < 0,05). Discussion / Conclusion : La batterie EMCS peut contribuer à identifier, en un temps relativement court, des troubles sémantiques multimodaux chez des patients souffrant d’aphasie vasculaire et dégénérative. Ainsi, cet outil peut être une aide au diagnostic clinique et offre au clinicien la possibilité de déterminer, à un stade précoce, la nature de l’atteinte sémantique (accès ou centrale).

1 January 2021
Verified
Dataset
Closed access
ILIsabelle Simoes Loureiro
Isabelle Simoes Loureiro
MTMathilda Taverne
Mathilda Taverne
VMValentine Malou
Valentine Malou
Sandrine BASAGLIA-PAPPASSandrine BASAGLIA-PAPPAS
Sandrine BASAGLIA-PAPPAS
RBRomane Besin
Romane Besin
LLLaurent Lefebvre
Laurent Lefebvre

8 September 2026 in International Journal of Language & Communication Disorders
Verified
Journal Article
Open access
PDF file
AVAnna Volkmer
Anna Volkmer
RTRosemary Townsend
Rosemary Townsend
BABethany Anthony
Bethany Anthony
SASharon M. Antonucci
Sharon M. Antonucci
PBPetronilla Battista
Petronilla Battista
TGthe BCPPA Patient and Public Involvement Group
the BCPPA Patient and Public Involvement Group
Introduction: Globally, there is a lack of awareness of rare dementias such as those led by language decline (the primary progressive aphasias, PPA). The main treatment for PPA is speech and language therapy, yet many people are unaware of the benefits and are often not referred on by other health care professionals. Delays in diagnosis can exacerbate a delay in accessing resources such as speech and language therapy which can assist in maintenance of communication and independence. Some people affected by PPA are able to seek out information independently and navigate their own way to these services, but others experience substantial challenges in accessing support. This study was born out of discussions with people affected by PPA who identified an urgent need to raise awareness of PPA and the benefits of speech and language therapy. The aim of the project was to co‐develop a PPA awareness campaign and, through feedback, understand the impact of a co‐produced and delivered awareness campaign on awareness and knowledge of PPA and the role of the speech and language therapy. Methods: This study was informed by the People with Aphasia and Other Layperson Involvement (PAOLI) framework for guiding patient and public involvement (PPI) in aphasia research. Key components of the PPA awareness campaign were co‐developed at a World Café event with 30 people affected by PPA. Consequently, engagement data were collected from social media posts during the 10‐week campaign, and registration and attendance at the co‐planned webinars. A feedback survey was collected from attendees after the event, and a micro‐costing analysis conducted to understand the costs. Results: The 10‐week PPA awareness campaign focused on raising awareness of the role of speech and language therapy for PPA and a bespoke logo was developed that was shared across seven participating countries internationally. Attendees reported increased knowledge of the role of speech and language therapists and valued hearing the voices of people affected by PPA throughout the campaign. Webinar events were well attended across the participating countries with an average of 300 attendees, ranging from 233 in Greece to 369 in the UK. The cost of developing the awareness campaign was calculated at £26.20 per webinar attendee in the UK. Discussion: The PPA awareness campaign was conceived by people affected by PPA and aimed to increase awareness that speech and language therapy can support people affected by the condition. The awareness campaign developed iteratively and concluded with an awareness day event spanning seven‐countries internationally which are all now permanently accessible as resources on the International Speech and Language Therapist / Pathologist PPA network (International SLT/P PPA network) website. Future campaigns will take a more focused approach by targeting more specific audiences such as trainee doctors. The co‐development blueprint for the PPA awareness campaigns provides actionable, field‐tested recommendations for planning future health awareness initiatives. WHAT THIS PAPER ADDS: What is already known on the subject Primary Progressive Aphasia (PPA) is a rare language led dementia for which speech and language therapy is the main treatment. At present, people affected by PPA report a lack of information available about speech and language therapy. This can perpetuate feelings of loneliness and social isolation. What this paper adds to the existing knowledge This paper provides the key components of a co‐developed PPA awareness campaign and describes a collaboration across organisations and countries to deliver the first year of the PPA awareness campaign. Future PPA awareness campaigns will build on this, by targeting specific audiences and aiming to increase knowledge and awareness of the role of the speech and language therapist. What are the clinical implications of this study? Increasing awareness of PPA and the role of the speech and language therapist has been identified by people with lived experience in the UK, as the core care pathway for people with PPA and their families. The PPA awareness campaign has made this information available to people affected by PPA and health care professionals. This includes a set of recommendations for the development of future similar awareness campaigns beyond PPA.

20 June 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Sandrine BASAGLIA-PAPPASSandrine BASAGLIA-PAPPAS
Sandrine BASAGLIA-PAPPAS
HSHina Solignac
Hina Solignac
EDEdith Durand
Edith Durand
Background/Objectives: Verb anomia is a common symptom of primary progressive aphasia (PPA), particularly in the logopenic variant (lvPPA). Despite the central role of verbs in sentence construction, interventions specifically targeting verb anomia remain scarce. This study examined the effects of Personalized Observation, Execution and Mental Imagery (POEM) therapy, grounded in evidence that sensorimotor systems are recruited during action verb processing and may support verb retrieval. Methods: A 74-year-old woman with lvPPA completed pre- and post-POEM assessments (linguistic, cognitive, thymic, and motor). POEM consisted of 15 telepractice sessions delivered three times weekly using a systematic procedure with three sensorimotor strategies: action observation, gesture execution, and mental imagery. Results: No significant gains were observed in verb production across naming tasks, spontaneous speech, or functional communication contexts. However, co-verbal gesture use increased in frequency and quality, particularly during the naming of untrained verbs, suggesting that the gesture execution strategy was generalized. A delayed treatment effect was also noted, raising questions regarding the optimal duration of POEM in neurodegenerative conditions. Conclusions: While no statistically significant improvements in verb production were observed, qualitative analyses revealed increased use and quality of co-verbal gestures, suggesting that POEM had a compensatory effect. Future research involving larger cohorts and longer periods could help clarify the benefits of POEM therapy. It would also be relevant to compare in-person and remote delivery formats to evaluate POEM therapy’s robustness and adaptability in different clinical contexts. To conclude, these findings remain preliminary and should be interpreted with caution, particularly given the lack of significant improvement in primary verb production outcomes.